ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
3,655
Screening encounters
4,264
Diagnostic referrals
812
Outstanding pathways
293

Screening pathway

  1. Screening4,264Encounters
  2. Positive finding1,469Documented findings
  3. Referral812Diagnostic referrals
  4. Follow-up953Diagnostic visits
  5. Outcome519Resolved pathways

Stage totals use different units. Pending pathways: 293. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0131 · EXP-0131Synthetic · Site C

Full participant history through 2026-10-13, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-08-12
  4. · Diagnostic referral · EXP-0131-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Diagnostic visit · Attended
  8. · Diagnosis · Colposcopy · Biopsy collected
  9. · Diagnosis · Histopathology · No high-grade lesion identified
  10. · Surveillance plan · HPV DNA · After clinical assessment · Scheduled for 2027-04-16
  11. · Follow-up disposition · Resolved · EXP-0131-T-R

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Resolved

Screened participants

3655 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0096 · Expanded synthetic participant 0096Site E — Resource-Constrained Navigation Programme
EXP-0097 · Expanded synthetic participant 0097Site E — Resource-Constrained Navigation Programme
EXP-0098 · Expanded synthetic participant 0098Site A — Urban Referral Hub
EXP-0099 · Expanded synthetic participant 0099Site C — Rural Outreach Programme
EXP-0100 · Expanded synthetic participant 0100Site D — Community Engagement Programme
EXP-0101 · Expanded synthetic participant 0101Site C — Rural Outreach Programme
EXP-0102 · Expanded synthetic participant 0102Site A — Urban Referral Hub
EXP-0103 · Expanded synthetic participant 0103Site D — Community Engagement Programme
EXP-0104 · Expanded synthetic participant 0104Site A — Urban Referral Hub
EXP-0106 · Expanded synthetic participant 0106Site D — Community Engagement Programme
EXP-0107 · Expanded synthetic participant 0107Site E — Resource-Constrained Navigation Programme
EXP-0108 · Expanded synthetic participant 0108Site B — Peri-Urban Access Programme
EXP-0109 · Expanded synthetic participant 0109Site D — Community Engagement Programme
EXP-0110 · Expanded synthetic participant 0110Site A — Urban Referral Hub
EXP-0112 · Expanded synthetic participant 0112Site A — Urban Referral Hub
EXP-0114 · Expanded synthetic participant 0114Site D — Community Engagement Programme
EXP-0116 · Expanded synthetic participant 0116Site B — Peri-Urban Access Programme
EXP-0117 · Expanded synthetic participant 0117Site A — Urban Referral Hub
EXP-0119 · Expanded synthetic participant 0119Site A — Urban Referral Hub
EXP-0121 · Expanded synthetic participant 0121Site D — Community Engagement Programme
EXP-0122 · Expanded synthetic participant 0122Site E — Resource-Constrained Navigation Programme
EXP-0123 · Expanded synthetic participant 0123Site A — Urban Referral Hub
EXP-0124 · Expanded synthetic participant 0124Site D — Community Engagement Programme
EXP-0125 · Expanded synthetic participant 0125Site C — Rural Outreach Programme
EXP-0126 · Expanded synthetic participant 0126Site D — Community Engagement Programme

Programme insights

Encounters by modality

VIA
1659
HPV DNA
2006
Cytology
599

Navigation activity

Barrier documented
716
Contact attempt
1189
Navigation intervention
306
Diagnostic booking
1008
Diagnostic visit
953

Documented barriers

Contact difficulty
230
Transport difficulty
233
Appointment coordination
253

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.